SHOO STEVEN MADDEN, LTD.
Footwear, (No Rubber) · Nasdaq · SEC CIK 913241 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY20.4%
TTM net income YoY211.2%
TTM EPS YoY211.5%
Revenue 3-yr CAGR13.8%
Net income 3-yr CAGR1.2%
Margins
Gross margin46.8%
Operating margin8.7%
Net margin6.2%
FCF margin7.2%
EBITDA margin10.0%
Returns
ROE19.1%
ROA8.9%
ROIC (approx.)16.5%
Asset turnover1.44x
Leverage & solvency
Liabilities / assets47.9%
Debt / equity0.12x
Current ratio1.86x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.39x
Accruals ratio-3.5%
Payout ratio35.0%
Capex / revenue1.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2025*2025-12-31 | FY2024*2024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $2.53B | $2.28B |
| Cost of revenue | $1.48B | $1.35B |
| Gross profit | $1.05B | $936.93M |
| Operating income | $80.77M | $224.94M |
| Pretax income | $77.68M | $230.48M |
| Income tax | $28.66M | $54.58M |
| Net income | $44.66M | $169.39M |
| EBITDA | $114.21M | $244.95M |
| EPS (basic) | 0.63 | 2.38 |
| EPS (diluted) | 0.63 | 2.35 |
| Dividends declared per share | 0.84 | 0.84 |
| Weighted avg. shares (diluted) | 71.18M | 71.96M |
| Banking | ||
| Net interest income | -$12.34M | $5.54M |
| Balance sheet | ||
| Cash & equivalents | $112.42M | $189.92M |
| Short-term investments | $0 | $13.48M |
| Receivables | $7.12M | $4.67M |
| Inventory | $417.02M | $257.62M |
| Current assets | $1.00B | $894.70M |
| PP&E, net | $115.80M | $57.39M |
| Goodwill | $254.52M | $183.74M |
| Intangibles | $281.42M | $113.43M |
| Total assets | $1.91B | $1.41B |
| Current liabilities | $525.71M | $413.72M |
| Short-term debt | $0 | $0 |
| Long-term debt | $234.17M | $0 |
| Total debt | $234.17M | $0 |
| Total liabilities | $1.01B | $535.77M |
| Shareholders' equity | $866.39M | $847.72M |
| Net debt | $121.74M | -$189.92M |
| Shares outstanding | 72.67M | 72.16M |
| Cash flow statement | ||
| Operating cash flow | $162.20M | $198.10M |
| Capital expenditure | $42.66M | $25.91M |
| Free cash flow | $119.54M | $172.19M |
| Investing cash flow | -$400.92M | -$39.49M |
| Financing cash flow | $157.15M | -$167.91M |
| Depreciation & amortization | $33.44M | $20.01M |
| Stock-based compensation | $29.64M | $26.54M |
| Dividends paid | $60.96M | $61.04M |
| Share buybacks | $13.52M | $98.43M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.